Incontinence News and Research

Latest Incontinence News and Research

Tibial nerve stimulation reduces symptoms of overactive bladder, research finds

Beaumont Health System research finds that symptoms of overactive bladder, or OAB, were reduced in those who received tibial nerve stimulation. The three-year results published in the June issue of The Journal of Urology show participants with urinary frequency, urgency and involuntary loss of urine maintained significant improvement in their symptoms.

31 May 2013

Targacept initiates TC-5214 Phase 2b clinical study in patients with OAB

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of a Phase 2b clinical study of TC-5214 as a treatment for overactive bladder.

29 May 2013

Perrigo receives final approval for generic Sanctura XR

Perrigo Company today announced that it has received final approval for the generic version of Sanctura XR. Perrigo had previously prevailed in litigation at both the district and appellate levels. The product has begun shipping immediately.

29 May 2013

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

Frutarom Health, Switzerland, reports increased demand for Go-Less, its natural ingredient targeting urinary incontinence in adults.

28 May 2013

No significant benefit differences between IMRT and CRT therapies after prostatectomy

Use of the newer, more expensive intensity-modulated radiotherapy (IMRT) and use of the older conformal radiotherapy (CRT) after surgical removal of all or part of the prostate gland were associated with similar morbidity and cancer control outcomes, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.

21 May 2013

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA Department of Urology.

21 May 2013

Long-term success rates of surgery to treat pelvic organ prolapse are lower than expected

Research conducted by the Pelvic Floor Disorders Network, an initiative funded by the National Institutes of Health, has revealed that the long-term success rates of a surgery to treat pelvic organ prolapse are lower than expected. Nearly one-third of women develop anatomic or symptomatic treatment failure within five years of undergoing sacrocolpopexy for pelvic organ prolapse, according to a study published in the May 15 issue of JAMA.

17 May 2013

Abdominal sacrocolpopexy procedure effectively provides relief from POP symptoms

Results after seven years of follow-up suggest that women considering abdominal sacrocolpopexy (surgery for pelvic organ prolapse [POP]) should be counseled that this procedure effectively provides relief from POP symptoms; however, the anatomic support deteriorates over time; and that adding an anti-incontinence procedure decreases, but does not eliminate the risk of stress urinary incontinence, and mesh erosion can be a problem, according to a study in the May 15 issue of JAMA.

15 May 2013

Study evaluates durability of abdominal sacrocolpopexy for pelvic organ prolapse

The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.

15 May 2013

Uroplasty highlights results of STEP Study on PTNS treatments for overactive bladder

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today highlighted the 3-year results of the STEP Study on percutaneous tibial nerve stimulation treatments for overactive bladder using Uroplasty's Urgent PC Neuromodulation System.

10 May 2013

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain is caused by lesion or disease to the peripheral somatosensory nervous system. Nerve damage that can lead to peripheral neuropathic pain can happen as a result of a range of different diseases, medications or traumatic injuries.

8 May 2013

Gaining weight during pregnancy causes increased risk for tears during delivery

Excessive weight gain during pregnancy significantly increases the risk of lacerations during vaginal childbirth, according to a study conducted by researchers at Montefiore Medical Center.

8 May 2013

Nano-Tera provides funds for research and development of artificial sphincter

The lack of control over one's own bowel movements can severely affect an individual's quality of life. Researchers at the University of Basel want to develop an adaptive implant that would be able to contract and relax like a natural muscle.

22 Apr 2013

Study shows brachytherapy is underused in the UK

Better outcomes can be achieved for prostate cancer patients using brachytherapy, a highly targeted form of radiotherapy, compared to surgery - this is the finding of a new study conducted by PANAXEA, The University of Twente, Netherlands.

From Elekta 22 Apr 2013

CCS Medical named winner in national Competitive Bidding Program of CMS

CCS Medical, a leading provider of home delivery medical equipment and supplies, announced today that it has been named a winner in the national Competitive Bidding Program of the Centers for Medicare & Medicaid Services.

12 Apr 2013

American Cancer Society announces new research, training grants for fiscal year 2013

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 175 national research and training grants totaling $79,073,250 for fiscal year 2013.

9 Apr 2013

First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has dosed the first patient in its second Phase 2 clinical study with LiRIS, its novel product candidate, in patients with Interstitial Cystitis.

3 Apr 2013

Loyola researchers to evaluate impact of urinary incontinence on couple's relationship, sex life

A clinical trial is under way at Loyola University Health System to evaluate the impact of urge urinary incontinence on a couple's relationship and sex life.

30 Mar 2013

New way to predict woman’s final menstrual period

A new UCLA-led study suggests a way to predict when a woman will have her final menstrual period. The findings, published in the April issue of the peer-reviewed Journal of Clinical Endocrinology and Metabolism, could help women and physicians gauge the onset of menopause-related bone loss, which generally begins a year prior to the last period.

28 Mar 2013

ConservoCare obtains license options to develop nerve-block medical device for bladder control

ConservoCare, LLC, a spinoff of research at Case Western Reserve University, has obtained license options through the university's Technology Transfer Office to develop a medical device for bladder control.

16 Mar 2013

Incontinence News and Research

Latest Incontinence News and Research

Tibial nerve stimulation reduces symptoms of overactive bladder, research finds

Targacept initiates TC-5214 Phase 2b clinical study in patients with OAB

Perrigo receives final approval for generic Sanctura XR

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

No significant benefit differences between IMRT and CRT therapies after prostatectomy

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Long-term success rates of surgery to treat pelvic organ prolapse are lower than expected

Abdominal sacrocolpopexy procedure effectively provides relief from POP symptoms

Study evaluates durability of abdominal sacrocolpopexy for pelvic organ prolapse

Uroplasty highlights results of STEP Study on PTNS treatments for overactive bladder

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Gaining weight during pregnancy causes increased risk for tears during delivery

Nano-Tera provides funds for research and development of artificial sphincter

Study shows brachytherapy is underused in the UK

CCS Medical named winner in national Competitive Bidding Program of CMS

American Cancer Society announces new research, training grants for fiscal year 2013

First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

Loyola researchers to evaluate impact of urinary incontinence on couple's relationship, sex life

New way to predict woman’s final menstrual period

ConservoCare obtains license options to develop nerve-block medical device for bladder control

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Incontinence News and Research

Latest Incontinence News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in